Mainz Biomed N.V. (MYNZ)
NASDAQ: MYNZ · Real-Time Price · USD
2.540
+0.090 (3.67%)
At close: May 12, 2025, 4:00 PM
2.460
-0.080 (-3.15%)
After-hours: May 12, 2025, 7:41 PM EDT
Mainz Biomed Market Cap
Mainz Biomed has a market cap or net worth of $7.72 million as of May 12, 2025. Its market cap has decreased by -60.76% in one year.
Market Cap
7.72M
Enterprise Value
4.75M
1-Year Change
-60.76%
Ranking
Category
Stock Price
$2.54
Market Cap Chart
Since the IPO on November 5, 2021, Mainz Biomed's market cap has decreased from $58.55M to $7.72M, a decrease of -86.82%. That is a compound annual growth rate of -43.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 7.45M | -48.84% |
| Dec 31, 2024 | 14.55M | -38.37% |
| Dec 29, 2023 | 23.62M | -77.05% |
| Dec 30, 2022 | 102.90M | -17.54% |
| Dec 31, 2021 | 124.78M | 113.12% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |